In a momentous development, earlier this week the Government withdrew guidelines that enabled the National Pharmaceutical Pricing Authority (NPPA) exercise its powers to fix the prices of drugs that are not on the essential medicines list. It is pertinent to note that this withdrawal is prospective not retrospective; that is to say that this move will not reverse the price caps already placed. Brief recap of events: Last year around, May 2013 the Department of Pharmaceuticals (DOP) intervened and released...
↧